XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE STOCK PLANS (Tables)
3 Months Ended
Dec. 29, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs The table below summarizes the effect of recording share-based compensation expense and the option value of the employee stock purchase plan shares:
Three Months Ended
(In millions)December 29, 2023December 30, 2022
Cost of revenues$0.5 $0.4 
Research and development0.9 0.8 
Selling, general, and administrative
2.3 2.1 
Total share-based compensation expense$3.7 $3.3 
Schedule of Share-based Compensation, Stock Options, Activity The following table summarizes the activity for stock options under Varex’s employee incentive plans for the Company's employees:
(In thousands, except per share amounts and the remaining term)OptionsPrice Range
Weighted Average Exercise Price
Weighted Average Remaining Term (in years)
Aggregate Intrinsic Value(1)
Outstanding at September 29, 20232,862 
$13.61 - $37.60
$28.08 4.8$871.4 
Granted— 
$0.00 - $0.00
— 
Canceled, expired or forfeited— 
$0.00 - $0.00
— 
Outstanding at December 29, 20232,862 
$13.61 - $37.60
$28.08 4.6$1,159.0 
Exercisable at December 29, 20232,249 
$13.61 - $37.60
$29.01 3.6$937.8 
(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of $20.50 as of December 29, 2023, the last trading date of the Company's first quarter, and which represents the amount that would have been received by the option holders had all option holders exercised their in-the-money options and sold the shares received upon exercise as of that date.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity The following table summarizes the activity for restricted stock units, performance stock units, restricted stock awards, and deferred stock units under the 2020 Omnibus Stock Plan:
(In thousands, except per share amounts)Number of SharesWeighted Average Grant-Date Fair Value
Outstanding at September 29, 20231,277 $22.30 
Granted785 20.17 
Vested(142)28.04 
Canceled or expired(16)21.91 
Outstanding at December 29, 20231,904 $21.00